Spondylarthritis News and Research

RSS

Systematic approach needed to identify mental health issues in patients with inflammatory arthritis

Anxiety and depression are the mental health issues most commonly associated with inflammatory arthritis, and it is well-established that there is a link between mental health issues and poor health outcomes.

1 Jun 2023

Survey says half of people with rheumatoid disease struggle to pay for treatment

Rheumatoid disease encompasses inflammatory conditions that affect the joints, muscle, bones, and organs. A new study found that despite 90 of patients have health insurance, nearly 60 percent said that they are struggling to afford medication or treatment in the last year.

16 Sep 2019

NEJM publishes results of Cosentyx Phase III studies in ankylosing spondylitis

Novartis announced today that the results of the MEASURE 1 and MEASURE 2 Phase III studies for Cosentyx® (secukinumab) in ankylosing spondylitis (AS) were published in The New England Journal of Medicine (NEJM). These pivotal studies demonstrated significant clinical improvements with Cosentyx versus placebo in reducing the signs and symptoms of active AS – a long-term, painful and debilitating inflammation of the spine.

24 Dec 2015

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

MSD (Merck & Co., Inc., Kenilworth, New Jersey, USA) today announced that on 22 June the European Commission approved SIMPONI (golimumab) for the treatment of adult patients with severe, active non-radiographic axial spondyloarthritis (nr-axial SpA).

26 Jun 2015

Potential predictors of spinal damage progression in people with spondyloarthritis

The presence of syndesmophytes (bony growths in the spine), acute phase reactants (proteins that are released into the blood in response to inflammation), and smoking status can all serve as predictors for the progression of structural damage in the spine in people with spondyloarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

7 Nov 2011

Multicenter NIH trial finds combination antibiotics effective against Chlamydia-induced reactive arthritis

Combination antibiotics effectively treat Chlamydia-induced reactive arthritis - a major step toward management, and possibly cure, of this disease, a federal multicenter clinical trial led by the University of South Florida College of Medicine found.

29 Apr 2010

Combination of antibiotics can cure Chlamydia-induced ReA: Study

Researchers from University of South Florida College of Medicine found a combination of antibiotics to be an effective treatment for Chlamydia-induced reactive arthritis, a major step forward in the management, and possibly cure, of this disease. Results of this study are published in the May issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.

29 Apr 2010

Spondylarthritis News and Research

Systematic approach needed to identify mental health issues in patients with inflammatory arthritis

Survey says half of people with rheumatoid disease struggle to pay for treatment

NEJM publishes results of Cosentyx Phase III studies in ankylosing spondylitis

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

Potential predictors of spinal damage progression in people with spondyloarthritis

Multicenter NIH trial finds combination antibiotics effective against Chlamydia-induced reactive arthritis

Combination of antibiotics can cure Chlamydia-induced ReA: Study

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News